Mold-Tek Packaging Reports Robust Q1 Results with 22% Revenue Growth and Expanding Pharma Business
Mold-Tek Packaging Limited reported robust Q1 financial results, with revenue growing 22% year-over-year and net profit increasing by 35%. The company saw improvements across all segments, with the paint segment, supported by Aditya Birla Grasim, being a significant growth driver. The pharma segment achieved breakeven and grew 11% compared to Q4. Despite early monsoons affecting the Food & FMCG segment, it still recorded 16% growth. The company processed a total of 11,400 tons across all segments and saw per kg sales revenue increase from INR 198.00 to INR 211.00. Mold-Tek is expanding its operations, with new production starting in Panipat and additional investments planned for pharma capacity.
28Jul 25
Mold-Tek Packaging Reports Robust Q1 Performance with 36% Surge in Net Profit
Mold-Tek Packaging Limited announced strong Q1 financial results with net profit up 36% to ₹224.00 crore. EBITDA increased to ₹468.00 crore, and EBITDA margin improved to 19.45%. The company appointed Mr. Ashish Kumar Gaggar as Secretarial Auditor for a 5-year term starting FY 2025-26, subject to shareholder approval.
21Jul 25
Mold-Tek Packaging Sets Board Meeting for Q1 FY2026 Results and Dividend Consideration
Mold-Tek Packaging Limited has scheduled a board meeting for July 28, 2025, to review Q1 FY2026 unaudited financial results and recommend a final dividend for FY2025. The company has implemented a trading window closure from July 1 to July 30, 2025, in compliance with regulations. The meeting's outcomes could significantly impact investor interest and stock performance.
Mold-Tek Packaging's Q4 results show revenue growth of 14.70% to ₹2.03 billion and EBITDA increase of 7.89% to ₹383.00 million. However, EBITDA margin decreased to 18.90% from 20.07%, and net profit declined by 9.29% to ₹163.00 million compared to the previous year. The company faces challenges in maintaining profitability despite revenue growth.